Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rani Therapeutics Holdings (RANI) Change in Account Payables (2020 - 2025)

Historic Change in Account Payables for Rani Therapeutics Holdings (RANI) over the last 6 years, with Q3 2025 value amounting to $669000.0.

  • Rani Therapeutics Holdings' Change in Account Payables fell 3688.68% to $669000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $901000.0, marking a year-over-year increase of 25333.33%. This contributed to the annual value of $711000.0 for FY2024, which is 21949.58% up from last year.
  • Per Rani Therapeutics Holdings' latest filing, its Change in Account Payables stood at $669000.0 for Q3 2025, which was down 3688.68% from $278000.0 recorded in Q2 2025.
  • In the past 5 years, Rani Therapeutics Holdings' Change in Account Payables registered a high of $1.1 million during Q3 2024, and its lowest value of -$663000.0 during Q4 2023.
  • For the 5-year period, Rani Therapeutics Holdings' Change in Account Payables averaged around $101578.9, with its median value being $131000.0 (2022).
  • In the last 5 years, Rani Therapeutics Holdings' Change in Account Payables skyrocketed by 36250.0% in 2022 and then crashed by 41145.04% in 2023.
  • Rani Therapeutics Holdings' Change in Account Payables (Quarter) stood at -$131000.0 in 2021, then crashed by 63.36% to -$214000.0 in 2022, then plummeted by 209.81% to -$663000.0 in 2023, then surged by 68.78% to -$207000.0 in 2024, then skyrocketed by 423.19% to $669000.0 in 2025.
  • Its last three reported values are $669000.0 in Q3 2025, $278000.0 for Q2 2025, and $161000.0 during Q1 2025.